Johnson & Johnson Q3 revenue beats expectations at $25.4 billion
GS Goldman Sachs Group Inc
$891.91 -0.23%
View chart & analysis → - 1Johnson & Johnson's third-quarter revenue reached $25.4 billion, exceeding the LSEG consensus estimate of $25.28 billion.
- 2Johnson & Johnson's adjusted earnings per share (EPS) for the July-September period was $2.59.
- 3Johnson & Johnson announced plans to spin off its orthopedic business in mid-2027.
So what's the key point?
Johnson & Johnson reported higher revenue than experts expected. The company plans to spin off its orthopedic business in mid-2027.
Source CNBC · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.